How an earnings call comment from Al Sandrock propelled an appeals court's reversal on a Biogen investor suit
The US Court of Appeals for the First Circuit yesterday reversed a lower court’s ruling on one specific claim linked to investor allegations that Biogen …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
